245 related articles for article (PubMed ID: 23775684)
21. Underlying mechanisms of urine storage dysfunction in rats with salt-loading hypertension.
Kurokawa T; Zha X; Ito H; Aoki Y; Akino H; Kobayashi M; Yokoyama O
Life Sci; 2015 Nov; 141():8-12. PubMed ID: 26390819
[TBL] [Abstract][Full Text] [Related]
22. Protective effect of telmisartan against progressive oxidative brain damage and synuclein phosphorylation in stroke-resistant spontaneously hypertensive rats.
Fukui Y; Yamashita T; Kurata T; Sato K; Lukic V; Hishikawa N; Deguchi K; Abe K
J Stroke Cerebrovasc Dis; 2014 Jul; 23(6):1545-53. PubMed ID: 24685992
[TBL] [Abstract][Full Text] [Related]
23. An angiotensin II type-I receptor blocker, olmesartan medoxomil, attenuates lipid peroxidation in renal injury induced by subtotal nephrectomy.
Takahashi T; Konta T; Takasaki S; Ichikawa K; Takeishi Y; Kubota I
Clin Exp Nephrol; 2007 Sep; 11(3):202-208. PubMed ID: 17891346
[TBL] [Abstract][Full Text] [Related]
24. Effect of an angiotensin II receptor blocker and a calcium channel blocker on hypertension associated penile dysfunction in a rat model.
Shimizu S; Tsounapi P; Honda M; Dimitriadis F; Taniuchi K; Shimizu T; Inoue K; Saito M
Biomed Res; 2014; 35(3):215-21. PubMed ID: 24942861
[TBL] [Abstract][Full Text] [Related]
25. Olmesartan, an angiotensin II receptor blocker inhibits the progression of cataract formation in cadmium chloride induced hypertensive albino rats.
Choudhary R; Bodakhe SH
Life Sci; 2016 Dec; 167():105-112. PubMed ID: 27744053
[TBL] [Abstract][Full Text] [Related]
26. Synergistic neuroprotective effects of combined treatment with olmesartan plus azelnidipine in stroke-prone spontaneously hypertensive rats.
Omote Y; Deguchi K; Kono S; Liu W; Kurata T; Hishikawa N; Yamashita T; Ikeda Y; Abe K
J Neurosci Res; 2014 Oct; 92(10):1330-7. PubMed ID: 24839960
[TBL] [Abstract][Full Text] [Related]
27. Effect of Olmesartan on serum cystatin C levels in the patients with essential hypertension.
Koc Y; Mazi E; Sakaci T; Basturk T; Damar AB; Ahbap E; Unsal A; Borlu F
Eur Rev Med Pharmacol Sci; 2011 Dec; 15(12):1389-94. PubMed ID: 22288300
[TBL] [Abstract][Full Text] [Related]
28. Attenuation of hypertension-mediated glomerulosclerosis in conjunction with increased angiotensin (1-7).
Igase M; Yokoyama H; Ferrario CM
Ther Adv Cardiovasc Dis; 2011 Dec; 5(6):297-304. PubMed ID: 22089474
[TBL] [Abstract][Full Text] [Related]
29. Effects of olmesartan medoxomil as an angiotensin II-receptor blocker in chronic hypoxic rats.
Nakamoto T; Harasawa H; Akimoto K; Hirata H; Kaneko H; Kaneko N; Sorimachi K
Eur J Pharmacol; 2005 Dec; 528(1-3):43-51. PubMed ID: 16336959
[TBL] [Abstract][Full Text] [Related]
30. Telmisartan reduces progressive oxidative stress and phosphorylated α-synuclein accumulation in stroke-resistant spontaneously hypertensive rats after transient middle cerebral artery occlusion.
Sato K; Yamashita T; Kurata T; Lukic V; Fukui Y; Hishikawa N; Deguchi K; Abe K
J Stroke Cerebrovasc Dis; 2014 Jul; 23(6):1554-63. PubMed ID: 24780412
[TBL] [Abstract][Full Text] [Related]
31. Effects of silodosin and tadalafil on bladder dysfunction in spontaneously hypertensive rats: Possible role of bladder blood flow.
Nagao Y; Shimizu S; Kurabayashi A; Shimizu T; Tsuda M; Higashi Y; Fujieda M; Saito M
Int J Urol; 2020 Mar; 27(3):258-265. PubMed ID: 31944397
[TBL] [Abstract][Full Text] [Related]
32. Olmesartan improves endothelial function in hypertensive patients: link with extracellular superoxide dismutase.
Takiguchi S; Ayaori M; Uto-Kondo H; Iizuka M; Sasaki M; Komatsu T; Takase B; Adachi T; Ohsuzu F; Ikewaki K
Hypertens Res; 2011 Jun; 34(6):686-92. PubMed ID: 21307868
[TBL] [Abstract][Full Text] [Related]
33. "Pulse" treatment with high-dose angiotensin blocker reverses renal arteriolar hypertrophy and regresses hypertension.
Ishiguro K; Hayashi K; Sasamura H; Sakamaki Y; Itoh H
Hypertension; 2009 Jan; 53(1):83-9. PubMed ID: 19047581
[TBL] [Abstract][Full Text] [Related]
34. Effect of silodosin, a selective α(1A)-adrenoceptor antagonist, on voiding behavior and bladder blood flow in a rat model of bladder outlet obstruction.
Goi Y; Tomiyama Y; Yokoyama A; Tatemichi S; Maruyama K; Kobayashi M; Yamaguchi O
Eur J Pharmacol; 2015 Oct; 764():489-496. PubMed ID: 26189024
[TBL] [Abstract][Full Text] [Related]
35. Effects of olmesartan and enalapril at low or high doses on cardiac, renal and vascular interstitial matrix in spontaneously hypertensive rats.
Porteri E; Rodella L; Rizzoni D; Rezzani R; Paiardi S; Sleiman I; De Ciuceis C; Boari GE; Castellano M; Bianchi R; Agabiti-Rosei E
Blood Press; 2005; 14(3):184-92. PubMed ID: 16036499
[TBL] [Abstract][Full Text] [Related]
36. Identification of potential therapeutic targets in hypertension-associated bladder dysfunction.
Yono M; Yoshida M; Yamamoto Y; Imanishi A; Fukagawa A; Latifpour J; Eto M
BJU Int; 2010 Mar; 105(6):877-83. PubMed ID: 19689474
[TBL] [Abstract][Full Text] [Related]
37. Direct angiotensin II type 2 receptor stimulation in Nω-nitro-L-arginine-methyl ester-induced hypertension: the effect on pulse wave velocity and aortic remodeling.
Paulis L; Becker ST; Lucht K; Schwengel K; Slavic S; Kaschina E; Thöne-Reineke C; Dahlöf B; Baulmann J; Unger T; Steckelings UM
Hypertension; 2012 Feb; 59(2):485-92. PubMed ID: 22215717
[TBL] [Abstract][Full Text] [Related]
38. Favorable cardiac and aortic remodeling in olmesartan-treated spontaneously hypertensive rats.
Fernandes-Santos C; de Souza Mendonça L; Mandarim-de-Lacerda CA
Heart Vessels; 2009 May; 24(3):219-27. PubMed ID: 19466524
[TBL] [Abstract][Full Text] [Related]
39. Connective tissue growth factor induction in a pressure-overloaded heart ameliorated by the angiotensin II type 1 receptor blocker olmesartan.
Iwamoto M; Hirohata S; Ogawa H; Ohtsuki T; Shinohata R; Miyoshi T; Hatipoglu FO; Kusachi S; Yamamoto K; Ninomiya Y
Hypertens Res; 2010 Dec; 33(12):1305-11. PubMed ID: 20944640
[TBL] [Abstract][Full Text] [Related]
40. Protective effects of the angiotensin II type 1 (AT1) receptor blockade in low-renin deoxycorticosterone acetate (DOCA)-treated spontaneously hypertensive rats.
Chamorro V; Wangensteen R; Sainz J; Duarte J; O'Valle F; Osuna A; Vargas F
Clin Sci (Lond); 2004 Mar; 106(3):251-9. PubMed ID: 14521506
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
